Form 4 for CAC CAMDEN NATIONAL CORP
Accepted 2023-09-22 00:00:00 ET · period of report 2023-09-20 · accession 0000750686-23-000273 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-22 | 2023-09-20 | CAC | Flanagan David C | Dir | A - Grant | $29.11 | +674 | 28.4K | +2% | +$19.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-20 | A | A | 674 | $29.11 | 28,367.94 | D | — | — | (F1) Shares acquired under Camden National Corporation's 2022 Equity and Incentive Plan in lieu of director fees. (F2) Consists of 324.02 shares acquired since last filing as a result of participation in the Company's dividend reinvestment program. |